Generation of a sensitive TNFR2-specific murine assays system

Die Pharmazie
|June 29, 2016
PubMed

Insights

Researchers developed a new assay to specifically target mouse Tumor Necrosis Factor Receptor 2 (mTNFR2). This system enables the screening of agents that stimulate mTNFR2, crucial for understanding its role in diseases.

Area of Science:

  • Immunology and Molecular Biology
  • Drug Discovery and Development

Background:

  • Tumor Necrosis Factor (TNF) and its receptors (TNFR1/TNFR2) are implicated as therapeutic targets for autoimmune diseases and cancers.
  • The precise functions of TNF receptors, particularly TNFR2, remain incompletely elucidated, hindering targeted therapeutic development.

Purpose of the Study:

  • To establish a novel biological assay system for screening mouse TNFR2 (mTNFR2)-selective stimulating agents.
  • To develop a system that isolates mTNFR2 activity, excluding the influence of mouse TNFR1 (mTNFR1).

Main Methods:

  • Construction of a mouse TNFR1 knockout and TNFR2 knockout (mTNFR1(-/-)R2(-/-)) preadipocyte cell line.
  • Transfection of the cell line with a chimeric receptor gene encoding mTNFR2 fused with the intracellular domain of mouse Fas (mFas).
  • Evaluation of the cell line's sensitivity to mTNFR2-mediated cytotoxic effects.

Main Results:

  • The developed cell line demonstrated highly sensitive cytotoxic effects mediated specifically by mTNFR2.
  • The assay system effectively screened for mTNFR2-selective stimulating agents, independent of mTNFR1 activity.

Conclusions:

  • The novel mTNFR2-mediated biological assay system is a valuable tool for identifying mTNFR2-selective agonists.
  • This system facilitates further research into TNFR2 functions and the development of targeted therapies for refractory diseases.

Related Concept Videos